Neurizon Therapeutics LimitedASX: NUZ

Section 708A Cleansing Statement

· Issued by Neurizon Therapeutics Limited via ASX

Filed with ASX · · 2 pages · English

Release

Neurizon Therapeutics Limited ABN 35 094 006 023 www.neurizon.com 9 November 2026 Section 708A Cleansing Statement This notice is given by Neurizon Therapeutics Limited ACN 094 006 023 (ASX: NUZ) (Company) under section 708A(5)(e) of the Corporations Act 2001 (Cth) (Corporations Act). The Company...

Neurizon Therapeutics Limited on 6ix

Earlier from Neurizon Therapeutics

Later from Neurizon Therapeutics

All Neurizon Therapeutics news releases